Skip to main content
Clinical Trials/ACTRN12618001603202
ACTRN12618001603202
Completed
未知

Effect of Cerebral Blood Flow on Cognition Across Healthy Adulthood

Jim Cotter0 sites28 target enrollmentSeptember 27, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Jim Cotter
Enrollment
28
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

At baseline, older adults had lower cognitive performance and CBF, but similar cerebrovascular reactivity to CO2 and dynamic cerebral autoregulation compared to young adults. In both young and older adults, cognitive performance on a mental switching task was slightly (7%) reduced after indomethacin, but not significantly associated with reductions in CBF (~31%). These results indicate that cognitive performance is broadly resilient against a ~31% reduction in CBF per se in healthy young and older adults.

Registry
who.int
Start Date
September 27, 2018
End Date
February 4, 2019
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Jim Cotter

Eligibility Criteria

Inclusion Criteria

  • No signs of cognitive impairment and non\-smoker.

Exclusion Criteria

  • Currently taking, or required to take any medication listed below:
  • oCardiac glycosides
  • oAminoglycosides
  • oAnticoagulants
  • oAntihypertensive
  • oNon\-steroidal anti\-inflammatories
  • oCorticosteroids
  • Known cardiovascular, cerebrovascular, neurological, metabolic, respiratory, renal, or haematological disease or condition.
  • Allergic to NSAIDs.

Outcomes

Primary Outcomes

Not specified

Similar Trials